VANDA PHARMACEUTICALS INC's ticker is and the CUSIP is 921659908. A total of 4 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $802,000 | -61.3% | 503 | -59.7% | 0.05% | -39.7% |
| Q3 2016 | $2,075,000 | +33.4% | 1,247 | -10.3% | 0.08% | -3.7% |
| Q2 2016 | $1,555,000 | -17.2% | 1,390 | -31.2% | 0.08% | +3.8% |
| Q1 2015 | $1,878,000 | +162.3% | 2,019 | +303.8% | 0.08% | +239.1% |
| Q4 2014 | $716,000 | -64.2% | 500 | -84.9% | 0.02% | -70.1% |
| Q3 2014 | $1,999,000 | -27.3% | 3,316 | +95.1% | 0.08% | -34.7% |
| Q2 2014 | $2,751,000 | +37.3% | 1,700 | -7.0% | 0.12% | -9.2% |
| Q3 2013 | $2,004,000 | – | 1,827 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 100,000 | $1,038,000 | 0.56% |
| SABBY MANAGEMENT, LLC | 3,316 | $1,999,000 | 0.08% |
| GROUP ONE TRADING, L.P. | 118,500 | $1,230,000 | 0.02% |
| Citadel Advisors | 30,400 | $316,000 | 0.00% |